Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block

NARecruitingINTERVENTIONAL
Enrollment

32

Participants

Timeline

Start Date

September 15, 2025

Primary Completion Date

January 25, 2026

Study Completion Date

January 25, 2026

Conditions
Pain
Interventions
DRUG

Ropivacaine (Epidural analgesia)

The block solution will consist of 1% ropivacaine 3 mg/Kg ideal body weight (IBW) mixed with dexmedetomidine 0.5 mcg/Kg IBW and diluted with 10 mL iohexol 300 mg/mL and normal saline for a total volume of 40 mL. All medications used are standard of care

DRUG

Dexmedetomidine

The block solution will consist of 1% ropivacaine 3 mg/Kg ideal body weight (IBW) mixed with dexmedetomidine 0.5 mcg/Kg IBW and diluted with 10 mL iohexol 300 mg/mL and normal saline for a total volume of 40 mL. All medications used are standard of care

DRUG

Iohexol

The block solution will consist of 1% ropivacaine 3 mg/Kg ideal body weight (IBW) mixed with dexmedetomidine 0.5 mcg/Kg IBW and diluted with 10 mL iohexol 300 mg/mL and normal saline for a total volume of 40 mL. All medications used are standard of care except for iohexol which is used for study purposes.

PROCEDURE

QST Procedure

The QST procedure (test of buzzing sensation and temperature sensation through pads applied to your skin) to assess the numb areas.

Trial Locations (1)

44106

RECRUITING

University Hospitals Cleveland Medical Center, Cleveland

All Listed Sponsors
lead

University Hospitals Cleveland Medical Center

OTHER

NCT07174440 - Contrast and Anesthetic Level With Lumbar Erector Spinae Plan (ESP) Block | Biotech Hunter | Biotech Hunter